Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Keiko who wrote (7345)	11/4/1997 11:42:00 PM
From: Decci	Read Replies (2) \| Respond to of 14328

Keiko, Conference call in the A.M. Wednesday. I received the information concerning the call by pager, I believe it is at 1000 Eastern time. I will post the particulars tomorrow morning as early as I can. I will make sure it is in time for all to listen. Ron I left a message on your answering machine. Topic is "Earnings". Ronan and Brendan will undoubtedly take questions. I think the future UniGold products is the jewel in our crown for now. Worldwide distribution, we sometimes get confused about the US market not being the only viable sales opportunities for TRIBY products. Each news release revealed great news for us, however, our price erodes. I think (GULP) we should push for a REVERSE SPLIT. Reduce the number of outstanding shares and leave the NASDAQ. I know I will take heat for that comment, but I believe another exchange would serve us better and in the long run we will score big. 3 to 1 reverse would leave about 7 million (est) shares at a price of around $7.75 (est), giving us a chance at the NYSE. True supply and demand, instead of the MM's carrying inventories of stock waiting to give a BUY recommendation, and then offering their inventory for sale at a higher price. This is a form of supply and demand, but not the best situation for an investor. I invite the critics. Just remember, this is my opinion. We are not yet a MSFT or an AMGN, we need some spark! This proposal might work. Many might bail at first, those that hold on should reap a sizeable harvest. .-. OUT

To: Keiko who wrote (7345)	11/5/1997 12:54:00 AM
From: Leslie S. Feinberg	Respond to of 14328

Keiko: Let's help put some of those hardcore unemployed Dubliners to work...making uni-gold tests! El Scripto P.S. Keiko, have you heard about a new issue called C3 (CTHR) to come out next week. They are a spinoff of Cree Research. They make a SiC synthetic gemstone far superior to any other synthetics and they have a patented process. The buzz is cubic zirconium is a $1 billion business, natural diamond is a $17 billion business, and the SiC gems known as Moissonite will be somewhere in between. Looks pretty hot.

To: Keiko who wrote (7345)	11/5/1997 6:01:00 PM
From: Ace	Read Replies (1) \| Respond to of 14328

To All : Thumbs down on the split ... A bit of info from ISSN 0790 1747 Trinity Biotech has received a $600,000 marketing assistance package from the Irish Trade Board to help with the European launch of its Uni-Gold immunodiagnostic rapid tests. The funds will be made available over a 2 year period and will be repaid through a royalty on European sales commencing in the 3rd year of the program.. Future Uni-Gold products for Chlamydia and H. pylorii will be launched in the lst quarter of 1998 and a Strep. A product in the 2nd quarter. A prostate specific antigen product is due in the 3rd quarter while a test for Hepatitis A, in conjunction with Smithkline Beecham is due for the final quarter of 1998. Other products in the pipeline include tests for Hepatitis C, HIV and Influenza which Trinity hope to launch in 1999. According to company officials the market for its diagnostic products is currently worth $18 billion and growing rapidly.